Crohn’s Disease — Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report — 2023 To 2033
Crohn’s disease, classified as a type of inflammatory bowel disease (IBD), results in inflammation of the tissues within your digestive tract, leading to symptoms such as abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. The inflammation associated with Crohn’s disease can affect various parts of the digestive tract in different individuals, with the small intestine being the most commonly affected area. Typically, this inflammation extends into the deeper layers of the bowel. The development of Crohn’s disease is believed to be influenced by a combination of genetic susceptibility, environmental factors, and the composition of the intestinal microflora. These factors contribute to an abnormal mucosal immune response and impaired epithelial barrier function. There are five distinct types of Crohn’s Disease, each characterized as follows:
1. Ileocolitis: Inflammation occurs in the ileum and colon, accompanied by symptoms like diarrhea, abdominal cramps, and weight loss.
2. Ileitis: This subtype involves the formation of fistulas in the lower right abdomen.
3. Gastroduodenal Crohn’s disease: Inflammation affects the stomach and duodenum, leading to nausea and loss of appetite.
4. Jejunoileitis: This subtype features areas of inflammation in the duodenum, with symptoms including fistulas, diarrhea, and cramps.
5. Crohn’s colitis: Inflammation targets the colon and may manifest with skin lesions, fistulas, and joint pain.
Thelansis’s “Crohn’s Disease Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report — 2023 To 2033” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Crohn’s Disease treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights of Crohn’s Disease across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Crohn’s Disease Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Tags: Crohn’s Disease, Crohn’s Disease market outlook, Crohn’s Disease competitive landscape, Crohn’s Disease market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)
